Skip to Main Content

Paper Details

Endpoints for clinical trials in ophthalmology.
Prog Retin Eye Res
11
2023
Author NameAffiliation
Leopold SchmettererSingapore Eye Research Institute, Singapore Academic Clinical Program, Duke-NUS Medical School, Nanyang Technological University, Medical University Vienna, Austria Center for Medical Physics and Biomedical Engineering, Austria Institute of Molecular and Clinical Ophthalmology
Hendrik P N SchollInstitute of Molecular and Clinical Ophthalmology, University of Basel
SriniVas R SaddaDoheny Eye Institute, David Geffen School of Medicine at University of California los angeles
  • 1 - 3

Datasets

Release 1.2